CHURCHILL CAP C/SH (NYSE:CCC) and Global Cord Blood (NYSE:CO) are both small-cap unclassified companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.
Global Cord Blood pays an annual dividend of $0.08 per share and has a dividend yield of 1.2%. CHURCHILL CAP C/SH does not pay a dividend.
Institutional and Insider Ownership
41.1% of CHURCHILL CAP C/SH shares are held by institutional investors. Comparatively, 17.6% of Global Cord Blood shares are held by institutional investors. 2.3% of CHURCHILL CAP C/SH shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Earnings and Valuation
This table compares CHURCHILL CAP C/SH and Global Cord Blood’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|CHURCHILL CAP C/SH||N/A||N/A||$1.24 million||N/A||N/A|
|Global Cord Blood||$149.34 million||5.62||$37.79 million||N/A||N/A|
Global Cord Blood has higher revenue and earnings than CHURCHILL CAP C/SH.
This table compares CHURCHILL CAP C/SH and Global Cord Blood’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|CHURCHILL CAP C/SH||N/A||N/A||N/A|
|Global Cord Blood||23.64%||7.10%||3.75%|
This is a breakdown of current ratings and recommmendations for CHURCHILL CAP C/SH and Global Cord Blood, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|CHURCHILL CAP C/SH||0||0||0||0||N/A|
|Global Cord Blood||0||0||0||0||N/A|
Global Cord Blood beats CHURCHILL CAP C/SH on 6 of the 8 factors compared between the two stocks.
About CHURCHILL CAP C/SH
Churchill Capital Corp focuses on merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2018 and is based in New York, New York.
About Global Cord Blood
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).
Receive News & Ratings for CHURCHILL CAP C/SH Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CHURCHILL CAP C/SH and related companies with MarketBeat.com's FREE daily email newsletter.